Guardian Pharmacy Services, Inc (GRDN) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. Analyst target reached at $36.72 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: ALFs and BHFs.
Guardian Pharmacy Services operates 61 pharmacies serving approximately 205,000 residents in 8,400 long-term care facilities across 38 states, focused on assisted living and behavioral health facilities. Over two-thirds of annual revenue comes from ALF and BHF residents; the... Read more
Sell if holding. Analyst target reached at $36.72 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: ALFs and BHFs. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.4/10, moderate confidence.
Passes 3/6 gates (clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerALFs and BHFs10-K Item 1A: 'More than two-thirds of our annual revenue for each of the past three years has been generated from residents of ALFs and BHFs, which are our target markets'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $36.72 — A.R:R is negative (-0.4) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: ALFs and BHFs. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $34.49. Score 5.4/10, moderate confidence.
Take-profit target: $40.53 (+10.8% upside). Prior stop was $34.49. Stop-loss: $34.49.
Concentration risk — Customer: ALFs and BHFs; Analyst target reached - limited upside remaining; Earnings in 6 days (event risk).
Guardian Pharmacy Services, Inc trades at a P/E of 48.2 (forward 27.9). TrendMatrix value score: 5.3/10. Verdict: Sell.
11 analysts cover GRDN with a consensus score of 4.4/5. Average price target: $41.
What does Guardian Pharmacy Services, Inc do?Guardian Pharmacy Services operates 61 pharmacies serving approximately 205,000 residents in 8,400 long-term care...
Guardian Pharmacy Services operates 61 pharmacies serving approximately 205,000 residents in 8,400 long-term care facilities across 38 states, focused on assisted living and behavioral health facilities. Over two-thirds of annual revenue comes from ALF and BHF residents; the remainder primarily from skilled nursing facilities.